CorVel Corp (CRVL) Shares Oversold with RSI at 29.8

Written by Emily J. Thompson, Senior Investment Analyst

Source: NASDAQ.COM

Updated: Jan 02 2026

0mins

CRVL+0.79%

Should l Buy CRVL?

Source: NASDAQ.COM

Oversold Signal: CorVel Corp (CRVL) shares fell to $65.61, with an RSI of 29.8, indicating that the recent heavy selling may be nearing exhaustion, thus providing potential entry points for bullish investors.
Market Comparison: Compared to the S&P 500 ETF (SPY) RSI of 53.2, CRVL's oversold condition may attract investor attention, particularly amid increasing market volatility.
Historical Performance: With a 52-week low of $65.54 and a high of $128.61, CRVL's current trading price of $65.74 suggests the stock is hovering at low levels, potentially offering value investment opportunities for investors.
Investor Sentiment: As CRVL's shares remain oversold, investors may reassess their strategies to seek potential gains during market recoveries, which could further influence market sentiment and trading activity.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy CRVL?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on CRVL

About CRVL

CorVel Corporation applies technology, including artificial intelligence, machine learning and natural language processing, to enhance the management of episodes of care and the related health-care costs. The Company partners with employers, third-party administrators, insurance companies and government agencies to assist its customers in managing the medical costs of workers compensation, group health and auto insurance, and in monitoring the quality of care provided to claimants. Its services include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care and Medicare services. It delivers its solutions in three ways - as a fully integrated claims-management program, as discrete standalone services, or as targeted add-ons that enhance an existing client workflow. Integrated, end-to-end bundled programs are designed primarily for buyers such as self-insured employers who want a single, turnkey partner.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

CorVel Reports Strong Q3 Earnings with $236M Revenue

Feb 03 2026seekingalpha

Earnings Highlights: CorVel reported a GAAP EPS of $0.47 for Q3, with revenue reaching $236 million, reflecting a 3.5% year-over-year growth, indicating the company's ability to maintain stability in a competitive market.
Cash Position: At the end of the quarter, CorVel had $230 million in cash and cash equivalents with no borrowings, providing robust financial support for future investments and expansion opportunities.
Stock Buyback Program: During the quarter, CorVel repurchased $13.4 million worth of common stock, which not only reflects the company's confidence in its value but may also enhance EPS and shareholder returns.
Market Risk Warning: Despite strong financial performance, analysts caution that the rapid proliferation of artificial intelligence could pose potential risks to the company's business model, necessitating close monitoring of market dynamics to formulate responsive strategies.